Contract research organization throws down the gauntlet. Waters accepts the challenge.
That’s what the scientists at HFL Sport Science, one of the world's premier independent drug surveillance laboratories, said to their Waters UK representative after he was done touting the capabilities of the new ACQUITY UPLC System. As a CRO known for their knowledge of new technology, they simply couldn’t believe what they were hearing.
So a two-week test run was arranged.
HFL Sport Science wasted no time putting the instrument through its paces, placing it on the front end of two mass spectrometers, analyzing a daunting variety of assays. First they noticed how easy it was to use the instrumentation. Second, its lightning speed. Third, the remarkable sensitivity. And fourth, the results. The combination of more speed and greater sensitivity added up to the highest quality of data they had ever seen before.
At the end of the two-week trial period, as they wheeled the ACQUITY UPLC System out of the lab, there were rumored to be claw marks on its sides from the analysts who didn’t want to give it up.
It didn’t take HFL Sport Science long to buy 18 ACQUITY UPLC Systems. They had wanted proof. And they had gotten it. They couldn’t be happier.